Simple Summary Among sarcomas, which are rare cancers, inflammatory myofibroblastic
tumors are extremely rare. Unlike other subtypes, this is a largely oncogene-driven …

Inflammatory myofibroblastic tumor (IMT) and its subtype epithelioid inflammatory
myofibroblastic sarcoma (EIMS) are rare soft‐tissue tumors. As about 50% of IMT and 100 …

Oncogenic TRK fusions induce cancer cell proliferation and engage critical cancer-related
downstream signaling pathways. These TRK fusions occur rarely, but in a diverse spectrum …

Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm with intermediate malignancy
characterized by a propensity for recurrence but a low metastatic rate. Diagnostic challenges …

Background Inflammatory myofibroblastic tumors (IMT) are rare, intermediate malignant
tumors harboring frequent somatic molecular rearrangements. The management of IMT has …

Objective: Unusual setting of medical care Background: The treatment of locally advanced
non-small cell lung cancer involves a combination of chemotherapy, surgery, and …

Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory
myofibroblastic tumor, characterized by more aggressive clinical course and nuclear …

Background Inflammatory myofibroblastic tumors (IMTs) are a spectrum of tumors that range
in morphology and biological behavior from benign, intermediate, to apparently malignant …

Inflammatory myofibroblastic tumors (IMTs) are known to be associated with anaplastic
lymphoma kinase (ALK) gene rearrangements. Other molecular alterations such as ROS …

Myofibroblastic tumor is a mesenchymal neoplasm composed of myofibroblastic spindle
cells with inflammatory infiltrate and considered to be of low-malignant potential tumor …